Related Experiment Videos
Integrating microarray gene expression object model and clinical document architecture for cancer genomics research.
Yu Rang Park1, Hye Won Lee, Ju Han Kim
1Seoul National University Biomedical Informatics (SNUBI) and Human Genome Research Institute, Seoul National University College of Medicine, Seoul, 110-799, Korea.
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|June 17, 2006
Summary
Integrating genomic and clinical data is key for cancer research. This study developed a method to combine Microarray Gene Expression Object Model (MAGE-OM) and Health Level Seven Clinical Document Architecture (HL7 CDA) for better cancer genomics data analysis.
Area of Science:
- Bioinformatics
- Genomics
- Clinical Informatics
Background:
- Systematic integration of genomic and clinical data is crucial for advancing cancer genomics research.
- Existing standards like Microarray Gene Expression Object Model (MAGE-OM) cover genomic data but lack clinical data integration.
- Health Level Seven Clinical Document Architecture (HL7 CDA) provides a framework for clinical information but lacks semantic definition for genomics.
Purpose of the Study:
- To design a data model for integrating genomic and clinical information for cancer research.
- To enable data model-level integration between MAGE-OM and HL7 CDA.
- To define content semantics for HL7 CDA to accommodate genomic data.
Main Methods:
- Developed an XML Schema document template with additional constraints for HL7 CDA.
- Extended HL7 CDA to incorporate semantic definitions for genomic data.
- Ensured compatibility with MAGE-OM for seamless data integration.
Main Results:
- Successfully designed a document template enabling semantic definition within HL7 CDA.
- Achieved data model-level integration of MAGE-OM and HL7 CDA.
- Created a framework for standardized integration of cancer genomics and clinical data.
Conclusions:
- The developed HL7 CDA-based template facilitates the integration of genomic and clinical data.
- This approach enhances the utility of cancer genomics research by enabling comprehensive data analysis.
- Standardized data integration is essential for advancing precision medicine in oncology.